<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2810211248
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ELAPRASE 2 mg/ml concentrate for solution for infusion
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        IDURSULFASE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Concentrate for solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        10363.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Cangene BioPharma Inc. (CBI) " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Cangene BioPharma Inc. (CBI) 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Takeda Pharmaceuticals International AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A16AB09
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Elaprase 2 mg/ml concentrate for solution for infusion. Each vial of 3 ml contains 6 mg of idursulfase.<br />Elaprase is used as enzyme replacement therapy to treat children and adults with Hunter syndrome (Mucopolysaccharidosis II) when the level of the enzyme iduronate-2-sulfatase in the body is lower than normal. If you suffer from Hunter syndrome, a carbohydrate called glycosaminoglycan which is normally broken down by your body is not broken down and slowly accumulates in various organs in your body. This causes cells to function abnormally, thereby causing problems for various organs in your body which can lead to tissue destruction and organ failure. Elaprase contains an active substance called idursulfase which works by acting as a replacement for the enzyme that is at a low level, thereby breaking down this carbohydrate in affected cells. Enzyme replacement therapy is usually administered as a long-term treatment</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Warnings and precautions</strong><br />Talk to your doctor or nurse before using Elaprase.<br />If you are treated with Elaprase you may experience side effects during or following an infusion (see section 4 Possible side effects). The most common symptoms are itching, rash, hives, fever, headache, increased blood pressure, and flushing (redness). Most of the time you can still be given Elaprase even if these symptoms occur. If you experience an allergic side effect following administration of Elaprase, you should contact your doctor immediately. You may be given additional medicines such as antihistamines and corticosteroids to treat or help prevent allergic-type reactions. If severe allergic reactions occur, your doctor will stop the infusion immediately, and start giving you suitable treatment. You may need to stay in hospital. The nature of your genotype may influence your therapeutic response to Elaprase, as well as your risk of developing antibodies and infusion-related adverse events; please consult your doctor.</p><p><u>Risk of Anaphylaxis</u><br />Life-threatening anaphylactic reactions have occurred in some patients during and up to 24 hours after Elaprase infusions, regardless of how long they had been taking Elaprase. Anaphylactic reactions are immediate and life-threatening reactions. Symptoms of anaphylactic reactions include breathing difficulties, low oxygen levels, low blood pressure, hives, and/or swelling of the throat or tongue. You will be closely monitored during, and for a period of time after, Elaprase infusions. If you have previously experienced an anaphylactic reaction, you may require prolonged observation&nbsp;following Elaprase infusions. Seek immediate medical care if any symptoms of an anaphylactic reaction occur.<br /><u>Risk of Acute Respiratory Complications</u><br />Patients with respiratory problems or those who have a fever or respiratory illness at the time of Elaprase infusion may be at a higher risk of life-threatening&nbsp;complications from allergic reactions. If you have any of these conditions, your Elaprase infusion may need to be delayed.<br /><u>Risk of Acute Cardiorespiratory Failure</u><br />Patients with respiratory illness or those with heart or respiratory problems may be at higher risk of fluid overload (too much fluid in the body) during Elaprase infusions. These patients may be at risk of serious worsening of their heart or respiratory function during infusions. If you are susceptible to fluid overload, you may require a prolonged observation time following your Elaprase infusion.</p><p><strong>Other medicines and Elaprase</strong><br />There is no known interaction of Elaprase with other medicines.&nbsp;<br />Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.<br /><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br /><strong>Driving and using machines</strong><br />Elaprase has no or negligible influence on the ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.<br />Elaprase will be given to you under the supervision of a doctor or nurse who is knowledgeable in the treatment of Hunter syndrome or other inherited metabolic disorders.<br />The recommended dose is an infusion of 0.5 mg (half a milligram) for every kg you weigh. Elaprase has to be diluted in 9 mg/ml (0.9%) sodium chloride solution for infusion before use. After dilution Elaprase is given through a vein (drip feed). The infusion will normally last for 1 to 3 hours and will be given every week.<br /><strong>Use in children and adolescents</strong><br />The recommended dosage in children and adolescents is the same as in adults.<br /><strong>If you use more Elaprase than you should</strong><br />There is no experience with overdoses of Elaprase.<br /><strong>If you forget to use Elaprase</strong><br />If you have missed an Elaprase infusion, please contact your doctor.<br />If you have any further questions on the use of this medicine, ask your doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />Most side effects are mild to moderate and associated with the infusion, however some<br />side effects may be serious. Over time the number of these infusion-associated reactions<br />decreases.<br />If you have problems breathing, with or without bluish skin, tell your doctor straight<br />away and seek immediate medical assistance.<br />Very common side effects (may affect more than 1 in 10 people) are:</p><ul><li>&nbsp;Headache</li><li>&nbsp;Increased blood pressure, flushing (redness)</li><li>&nbsp;Shortness of breath, wheezing</li><li>&nbsp;Abdominal pain, nausea, vomiting, indigestion, frequent and/or loose stools</li><li>&nbsp;Chest pain</li><li>&nbsp;Hives, rash, itching</li><li>&nbsp;Fever</li><li>&nbsp;Infusion site swelling</li><li>&nbsp;Infusion related reaction (see section entitled &ldquo;Warnings and precautions&rdquo;)</li></ul><p>Common side effects (may affect up to 1 in 10 people) are:</p><ul><li>&nbsp;Dizziness, tremor</li><li>&nbsp;Rapid heartbeat, irregular heartbeat, bluish skin</li><li>&nbsp;Decreased blood pressure</li><li>&nbsp;Difficulty breathing, cough, quickened breathing, low oxygen levels in your blood</li><li>&nbsp;Swollen tongue</li><li>&nbsp;Redness of the skin</li><li>&nbsp;Pain in the joints</li><li>&nbsp;Swelling of the extremities, facial swelling</li></ul><p>Side effects for which the frequency cannot be estimated from available data are:</p><ul><li>&nbsp;Serious allergic reactions</li></ul><p>If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>Keep this medicine out of the sight and reach of children.</li><li>Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.</li><li>Store in a refrigerator (2&deg;C &ndash; 8&deg;C)</li><li>Do not freeze</li><li>Do not use this medicine if you notice that there is discolouration or presence of foreign particles.</li><li>Do not throw away any medicines s via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is idursulfase, which is a form of the human enzyme iduronate‑2‑sulfatase. Idursulfase is produced in a human cell line by genetic engineering technology (it involves the introduction of genetic information into human cells in the lab, which will then produce the desired product).<br />Each vial of Elaprase contains 6 mg of idursulfase. Each ml contains 2 mg of idursulfase. The other ingredients are Polysorbate 20, sodium chloride, sodium phosphate dibasic, heptahydrate, sodium phosphate monobasic, monohydrate and water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Elaprase is a concentrate for solution for infusion. It is supplied in a glass vial as a clear to slightly opalescent, colorless solution.
Each vial contains 3 ml of concentrate for solution for infusion.
Elaprase is supplied in pack sizes of 1, 4 and 10 vials per carton
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder:</strong><br />Shire human Genetics Therapies AB, Pennf&auml;ktaren , 11 Vasagatan 7, 6th Floor Stockholm,<br />111 20 Sweden.<br /><strong>Manufacturers:</strong><br />-- Vetter Pharma-Fertigung GmbH &amp; Co. KG, Eisenbahnstrasse 2-4,<br />88085 Langenargen, Germany.<br />-- Cangene bioPharma, Inc. (CBI) 1111 South Paca Street ,Baltimore, MD 21230, USA<br /><strong>Batch release site:</strong><br />Shire Pharmaceuticals Ireland LTD, Block 2 &amp; 3 Miesian Plaza, 50-58 Baggot Street Lower,<br />Dublin 2, D02 Y754, Ireland<br />For any information about this medicinal product, please contact the local representative<br />of the Marketing Authorisation Holder:<br />Biologix FZ Co<br />Dubai Free Zone, Road WB 21, Warehouse, C17 PO Box 54405,<br />Al Tawar Dubai, United Arab Emirates<br />Telephone no.: 00971 4 299 7171</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 06/2017
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>دواء ايلابريز بتركيز 2 ملجم/مل لمحلول التسريب. تحتوى كل قنينة بسعة 3 ملم على 6 ملجم من مادة ايديورسالفيز.<br />يُستخدم دواء ايلابريز كعلاج بديل للأنزيمات لعلاج الأطفال والبالغين المصابين بمتلازمة هنتر (داء عديد السكاريد المخاطى من الدرجة الثانية) عندما تنخفض مستويات أنزيم أيدورونيت- 2- سلفاتاز عن المستوى الطبيعى فى الجسم، وإذا كنت تعانى من متلازمة هنتر، فهناك كربوهيدرات تسمى جلوكوز أمنيوغلايكين يحللها الجسم تحليلاً طبيعياً، وما يحدث هو أن تلك الكربوهيدرات لا تحلل وتتراكم ببطء فى مختلف أعضاء الجسم. وهذا يؤدى إلى خلل فى وظائف الخلايا؛ مما يتسبب فى مشكلات لمختلف أعضاء الجسم؛ وبالتالى قد تؤدى إلى تدمير الأنسجة وتوقف الأعضاء. يحتوى دواء إلابريز على مادة فعالة تسمى أيدرسولفيز والتى تعمل فى صورة بديل للأنزيم ذى المستوى المنخفض؛ وبالتالى تحلل تلك الكربوهيدرات فى الخلايا المتأثرة. وعادة ما يعطى العلاج<br />البديل للأنزيمات كعلاج طويل المدى.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>موانع استخدام ايلابريز:</strong><br />فى حالة الإصابة بتفاعلات حساسية حادة أو ربما مهددة للحياة تجاه مادة ايديورسالفيز أو أى من مكونات الدواء الأخرى (المدرجة فى القسم 6) ولا يمكن السيطرة على تلك التفاعلات بالعلاج الدوائى المناسب.<br /><strong>تحذيرات واحتياطات</strong></p><ul><li>خطر المضاعفات التنفسية الحادة</li></ul><p>قد يكون المرضى الذين يعانون من خلل في الوظائف التنفسية أو الحمى الحادة أو أمراض الجهاز التنفسي أكثر عرضة لخطر حدوث المضاعفات المهددة للحياة الناتجة عن تفاعلات الحساسية المفرطة أثناء تناول جرعات دواء إيلابريز.<br />يجب النظر بعناية للحالة الطبية للمرضى قبل تناول دواء إيلابريز، ودراسة تأخير جرعة دواء إيلابريز.<br />لقد عانى مريض واحد يعاني من مرض حاد في القصبة الهوائية والمجرى الهوائي والحمى الحادة، من ضيق التنفس، ونقص الأكسجة، والازرقاق، ونوبة صرعية مع فقدان الوعي خلال تناول جرعة دواء إيلابريز.</p><ul><li>خطر الفشل القلبي التنفسي الحاد</li></ul><p>يجب اتخاذ الحذر عند إعطاء جرعات إيلابريز للمرضى الذين يُشتبه في معاناتهم من زيادة السوائل أو المرضى الذين يعانون من الأمراض التنفسية الكامنة أو خلل في الوظائف القلبية و/أو التنفسية الموصوف لهم تقييد السوائل. حيث قد يكون هؤلاء المرضى عُرضة لخطر حدوث تفاقم حاد لحالاتهم القلبية أو التنفسية أثناء تناول الجرعات.<br />يجب توفير وتجهيز الدعم الطبي وتدابير الملاحظة أثناء تناول جرعات إيلابريز، وقد يحتاج بعض المرضى إلى الخضوع للملاحظة لفترات مطولة، والتي يجب أن تعتمد على احتياجات المريض الفردية<br />استشر الطبيب أو الممرضة قبل استخدام دواء ايلابريز.<br />عند الخضوع للعلاج بدواء ايلابريز، فقد تعانى آثاراً جانبية أثناء التسريب أو بعده (انظر القسم 4 المتعلق بالآثار الجانبية المحتملة).<br />وأشهر الأعراض هى الحكة والطفح الجلدى والشرى والحمى والصداع وإرتفاع ضغط الدم والاحمرار. وغالباً ما يمكنك العلاج بدواء ايلابريز، فينبغى الاتصال بالطبيب على الفور. فقد تعطى أدوية إضافية مثل مضادات الهيستامين والسترويدات القشرية لعلاج تفاعلات الحساسية أو المساعدة فى الوقاية منها.<br />وإذا حدثت تفاعلات حساسية حادة، سيوقف طبيبك التسريب على الفور،ويبدأ فى إعطائك الدواء المناسب. وقد تحتاج إلى البقاء فى المستشفى.<br />ربما يؤثر النمط الجينى لديك فى الاستجابة لعلاج دواء ايلابريز، وكذلك فى خطر تكَون أجسام مضادة والتعرض لحالات ضارة تتعلق بالتسريب؛ لذا يرجى استشارة الطبيب.</p><p><strong>استخدام الأدوية الأخرى مع دواء ايلابريز</strong><br />لا يوجد تفاعلات معروفة لدواء ايلابريز مع الأدوية الأخرى.<br />أخبر طبيبك أو الصيدلانى أو الممرضة إذا كنت تتناول أى أدوية أخرى أو تناولتها مؤخراً أو قد تناولها.<br /><strong>الحمل والرضاعة الطبيعية</strong><br />إذا كنت حاملاً أو ترضعين رضاعة طبيعية أو تعتقدين أنكِ ربما تكونين حاملاً أو تخططين للحمل، فاستشيرى طبيبك أو الصيدلانى<br />قبل تناول هذا الدواء.<br /><strong>القيادة واستخدام الآلات</strong><br />لا يوجد تأثير يُذكر لدواء ايلابريز على القدرة على القيادة أو استخدام الماكينات أو له تأثير ضئيل على ذلك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احرص دوما على استخدام هذا الدواء تماماً كما أخبرك طبيبك. استشر طبيبك إذا لم تكن متأكداً.<br />ستتناول دواء إلابريز تحت إشراف طبيب أو ممرضةعلى دراية بعلاج متلازمة هنتر أو غيرها من الاضطرابات الأيضية الموروثة.<br />الجرعة الموصى بها هى تسريب 0,5 ملجم )نصف ملجم( لكل كيلو جرام من وزنك.<br />ينبغى تخفيف دواء ايلابريز باستخدام 9 ملجم/ مل ) 0,9 %( من محلول كلوريد الصوديوم قبل الاستخدام للتسريب. ويُعطى دواء ايلابريز بعد تخفيفه عن طريق الوريد )التغذية بالتنقيط(. تتراوح المدة الطبيعية للتسريب ما بين ساعة إلى 3 ساعات وسيعطى كل أسبوع .<br /><strong>الاستخدام مع الأطفال والمراهقين</strong><br />الجرعة الموصى بها للأطفال والمراهقين هى ذاتها والمراهقين هى ذاتها الموصى بها للبالغين.<br /><strong>فى حالة استخدام جرعة أكبر مما ينبغى من دواء ايلابريز</strong><br />لا يوجد تجارب مع الجرعات الزائدة من دواء ايلابريز.<br /><strong>إذا نسيت استخدام دواء ايلابريز</strong><br />إذا فقدت جرعة تسريب من دواء إلابريز، فيرجى الاتصال بطبيبك.<br />إذا كانت لديك أى أسئلة إضافية عن استخدام هذا الدواء، فأسال الطبيب أو الممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>يمكن أن يتسبب هذا الدواء مثل جميع الأدوية فى حدوث آثار جانبية، على الرغم من عدم تعرض جميع المرضى لها.<br />تتسم معظم الآثار الجانبية بأنها خفيفة إلى متوسطة وتصاحب عملية التسريب، ولكن قد تكون بعض الآثار الجانبية خطيرة. ويقل عدد التفاعلات المصاحبة للتسريب بمرور الوقت.<br /><strong>إذا كنت تعانى مشكلات فى التنفس</strong>، سواء كان لون الجلد يميل إلى الزرقة أم لا، <strong>فأخبر الطبيب على الفور وأطلب المساعدة الطبية العاجلة</strong>.<br />الآثار الجانبية الشائعة للغاية (التى يمكن أن يتأثر بها أكثر من شخص من بين 10 أشخاص) هي:<br />&bull;&nbsp;&nbsp; &nbsp;الصداع<br />&bull;&nbsp;&nbsp; &nbsp;ارتفاع ضغط الدم، احمرار الجلد<br />&bull;&nbsp;&nbsp; &nbsp;ضيق التنفس، الأزيز<br />&bull;&nbsp;&nbsp; &nbsp;ألم البطن، الغثيان، القىء، عسر الهضم، البراز الرخو والمتكرر أو أى منهما<br />&bull;&nbsp;&nbsp; &nbsp;ألم فى الصدر<br />&bull;&nbsp;&nbsp; &nbsp;الشرى، الطفح الجلدى، الحكة<br />&bull;&nbsp;&nbsp; &nbsp;الحمى<br />&bull;&nbsp;&nbsp; &nbsp;تورم موضع التسريب<br />&bull;&nbsp;&nbsp; &nbsp;التفاعلات المرتبطة بالتسريب (انظر القسم عنوان &quot;تحذيرات واحتياطات&quot;)<br />الآثار الجانبية الشائعة (يمكن أن يتأثر بها ما يصل إلى 1 من كل 10 أشخاص):<br />&bull;&nbsp;&nbsp; &nbsp;الدوخة، الارتجاف<br />&bull;&nbsp;&nbsp; &nbsp;ضربات القلب السريعة، ضربات القلب غير المنتظمة، ميل لون الجلد إلى الزرقة<br />&bull;&nbsp;&nbsp; &nbsp;انخفاض ضغط الدم<br />&bull;&nbsp;&nbsp; &nbsp;صعوبة التنفس، السعال، سرعة التنفس، انخفاض مستويات الأكسجين فى الدم<br />&bull;&nbsp;&nbsp; &nbsp;توَرم اللسان<br />&bull;&nbsp;&nbsp; &nbsp;احمرار الجلد<br />&bull;&nbsp;&nbsp; &nbsp;ألم فى المفاصل<br />&bull;&nbsp;&nbsp; &nbsp;تورًم الأطراف، توًرم الوجه<br />الآثار الجانبية التى يتعذر تقدير حدوثها بناء على البيانات المتاحة هي:<br />&bull;&nbsp;&nbsp; &nbsp;تفاعلات الحساسية الخطيرة<br />إذا أصبت بأى آثار جانبية، فتحدث مع الطبيب أو الممرضة. يشمل هذا أى آثار جانبية غير مدرجة فى هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li>احفظ هذا الدواء بعيداً عن متناول الأطفال وأعينهم.</li><li>لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على الملصق والعلبة الكرتون بعد كلمة EXP.</li><li>يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.</li><li>يحفظ في الثلاجة في درجة الحرارة( 2 - 8 درجة مئوية) &nbsp;&nbsp;</li><li>لا تجمَد الدواء</li><li>لا تستخدم هذا الدواء إذا لاحظت تغيراً فى لونه أو وجود جسيمات غريبة.</li><li>لا تتخلص من أى أدوية عبر مياه الصرف الصحى أو المخلفات المنزلية. اسأل الصيدلانى الذى تتعامل معه عن طريقة التخلصمن الأدوية التى لم تعد تستخدمها. ستساعد هذه التدابير على حماية البيئة.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هى ايديورسالفيز، وهى أحد أشكال الأنزيم أيدورونيت- 2- سلفاتاز يُفرز أيدرسولفز فى خط الخلايا البشرية عن طريق تقنية الهندسة الجينية (وهى تتضمن تقديم المعلومات الجينية فى الخلايا البشرية فى المختبر؛ وعندئذ ستنتج المطلوب). تحتوى كل قنينة من دواء ايلابريز على 6 ملجم من مادة أيدرسولفيز. ويحتوى كل ملليلتر على 2 ملجم من ايديورسالفيز. المكونات الأخرى هى بولى سوريات 20 وكلوريد الصوديوم وفوسفات الصوديوم ثنائى القاعدة وخماسى هيدرات وفوسفات الصوديوم أحادى القاعدة وأحادى الهيدرات والمياه للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>دواء ايلابريز عبارة عن مركز لمحلول التسريب. ويُقدَم فى قنينة زجاجية فى صورة محلول شفاف إلى رائق ولا لون له تقريباً.<br />تحتوى كل قنينة على 3 مل من التركيز من المحلول للتسريب.<br />يورَد دواء ايلابريز فى عبوات تتسع لقنينة و 4 قنينات و 10 قنينات فى العلبة الواحدة<br />قد لا تتوفر جميع أحجام العبوات فى الأسواق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مالك تصريح السوق<br />Shire Human Genetic Therapies AB, Pennf&auml;ktaren 11 Vasagatan 7, 6th Floor Stockholm,<br />111 20 Sweden.<br />الجهات المصنعة<br />- Vetter Pharma- Fertigung GmbH &amp; CO. KG, Eissenbahnstrasse 2-4, 88085 Langenargen,<br />Germany.<br />- Cangene biopharma, Inc. (CBI) , Camden Industrial Park, 1111South Pace Street<br />Baltimore, MD 21230 USA<br />المصنع المسؤول عن فسح التشغيلة:<br />Shire Pharmaceuticals Ireland LTD, Block 2 &amp; 3 Miesian Plaza, 50-58 Baggot Street Lower,<br />Dublin 2, D02 Y754, Ireland<br />لأى معلومات اضافية عن هذا المستحضر، الرجاء الاتصال بالممثل المحلى للشركة مالكة حق التسويق:<br />شركة بيولوجيكس ف.ز كو وعنوانها: (Biologix FZ CO)<br />Dubia freez Zone, Road WB 21, Warehouse, c17 PO Box 54405<br />Al Tawar Dubai, United Arab Emirates.<br />هاتف رقم : 0097142997171</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة النشرة بتاريخ 06/2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Elaprase 2 mg/ml concentrate for solution for infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial contains 6 mg of idursulfase. Each ml contains 2 mg of idursulfase*.
Excipient with known effect
Each vial contains 0.482 mmol of sodium.
For the full list of excipients, see section 6.1.
* idursulfase is produced by recombinant DNA technology in a continuous human cell line.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concentrate for solution for infusion (sterile concentrate).
A clear to slightly opalescent, colourless solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Elaprase is indicated for the long-term treatment of patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II).<br />Heterozygous females were not studied in the clinical trials.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This treatment should be supervised by a physician or other healthcare professional experienced in the management of patients with MPS II disease or other inherited metabolic disorders.<br /><strong>Posology</strong><br />Elaprase is administered at a dose of 0.5 mg/kg body weight every week by intravenous infusion over a 3 hour period, which may be gradually reduced to 1 hour if no infusion-associated reactions are observed (see section 4.4).<br />For instruction for use, see section 6.6.<br />Infusion at home may be considered for patients who have received several months of treatment in the clinic and who are tolerating their infusions well. Home infusions should be performed under the surveillance of a physician or other healthcare professional.</p><p><strong>Special populations</strong><br /><u>Elderly patients</u><br />There is no clinical experience in patients over 65 years of age.<br /><u>Patients with renal or hepatic impairment</u><br />There is no clinical experience in patients with renal or hepatic insufficiency. (see section 5.2).<br /><u>Paediatric population</u><br />The dose for children and adolescents is the same as for adults, 0.5 mg/kg body weight weekly.<br /><u>Method of administration</u><br />For instructions on dilution of the medicinal product before administration, see section 6.6</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Severe or life-threatening hypersensitivity to the active substance or to any of the excipients if hypersensitivity is not controllable.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Infusion-related reactions</u><br />Patients treated with idursulfase may develop infusion-related reactions (see section 4.8). During clinical trials, the most common infusion-related reactions included cutaneous reactions (rash, pruritus, urticaria), pyrexia, headache, hypertension, and flushing. Infusion-related reactions were treated or ameliorated by slowing the infusion rate, interrupting the infusion, or by administration of medicinal products, such as antihistamines, antipyretics, low-dose corticosteroids (prednisone and methylprednisolone), or beta-agonist&nbsp;nebulisation. No patient discontinued treatment due to an infusion reaction during clinical studies.</p><p>Special care should be taken when administering an infusion in patients with severe underlying airway disease. These patients should be closely monitored and infused in an appropriate clinical setting. Caution must be exercised in the management and treatment of such patients by limitation or careful monitoring of antihistamine and other sedative medicinal product use. Institution of positive-airway pressure may be necessary in some cases.</p><p>Delaying the infusion in patients who present with an acute febrile respiratory illness should be considered. Patients using supplemental oxygen should have this treatment readily available during infusion in the event of an infusion-related reaction.</p><p><u>Anaphylactoid/anaphylactic reactions</u><br />Anaphylactoid/anaphylactic reactions, which have the potential to be life threatening, have been observed in some patients treated with idursulfase up to several years after initiating treatment. Late emergent symptoms and signs of anaphylactoid/anaphylactic reactions have been observed as long as 24 hours after an initial reaction. If an anaphylactoid/anaphylactic reaction occurs the infusion should be immediately suspended and appropriate treatment and observation initiated. The current medical standards for emergency treatment are to be observed. Patients experiencing severe or refractory anaphylactoid/anaphylactic reactions may require prolonged clinical monitoring. Patients who have experienced anaphylactoid/anaphylactic reactions should be treated with caution when readministering idursulfase, appropriately trained personnel and equipment for emergency resuscitation (including epinephrine) should be available during infusions. Severe or potentially life-threatening hypersensitivity is a contraindication to rechallenge, if hypersensitivity is not controllable (see section 4.3).</p><p><u>Patients with the complete deletion/large rearrangement genotype</u><br />Paediatric patients with the complete deletion/large rearrangement genotype have a high probability of developing antibodies, including neutralizing antibodies, in response to exposure to idursulfase. Patients with this genotype have a higher probability of developing infusion-related adverse events and tend to show a muted response as assessed by decrease in urinary output of glycosaminoglycans, liver size and spleen volume compared to patients with the missense genotype. Management of patients must be decided on an individual basis (see section 4.8).</p><p><br /><u>Sodium</u><br />This medicinal product contains 0.482 mmol sodium (or 11.1 mg) per vial. To be taken into consideration by patients on a controlled sodium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No formal medicinal product interaction studies have been conducted with idursulfase.<br />Based on its metabolism in cellular lysosomes, idursulfase would not be a candidate for cytochrome P450 mediated interactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u><br />There are no data or limited amount of data from the use of idursulfase in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3). As a precautionary measure, it is preferable to avoid the use of idursulfase during pregnancy.<br /><u>Breast-feeding</u><br />It is not known whether idursulfase is excreted in human breast milk. Available data in animals have shown excretion of idursulfase in milk (see section 5.3). A risk to the newborns/infants cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from idursulfase therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.<br /><u>Fertility</u><br />No effects on male fertility were seen in reproductive studies in male rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Idursulfase has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile</u><br />Adverse reactions that were reported for the 32 patients treated with 0.5 mg/kg idursulfase weekly in the TKT024 phase II/III 52-week placebo-controlled study were almost all mild to moderate in severity. The most common were infusion-related reactions, 202 of which were reported in 22 out of 32 patients following administration of a total of 1580 infusions. In the placebo treatment group 128 infusion-related reactions were reported in 21 out of 32 patients following administration of a total of 1612 infusions. Since more than one infusion-related reaction may have occurred during any single infusion, the above numbers are likely to over estimate the true incidence of infusion reactions. Related reactions in the placebo group were similar in nature and severity to those in the treated group. The most common of these infusion-related reactions included cutaneous reactions (rash, pruritus, urticaria), pyrexia, headache, hypertension and flushing. The frequency of infusion-related reactions decreased over time with continued treatment.</p><p><u>Tabulated list of adverse reactions</u><br />Adverse reactions are listed in table 1 with information presented by system organ class and frequency. Frequency is given as very common (&ge;1/10) or common (&ge;1/100 to &lt;1/10). The occurrence of an adverse reaction in a single patient is defined as common in view of the number of patients treated. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. Adverse reactions only reported during the post marketing period are also included in the table with a frequency &ldquo;not known&rdquo; (cannot be estimated from the available data).</p><p><strong>Table 1: Adverse reactions from clinical trials and post-marketing experience in patients<br />treated with Elaprase.</strong></p><p><strong><img alt="" width="539" height="467" src="data:image/png;base64,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" /></strong></p><p><u>Description of selected adverse reactions</u><br />Across clinical studies, serious adverse reactions were reported in a total of 5 patients who received 0.5 mg/kg weekly or every other week. Four patients experienced a hypoxic episode during one or several infusions, which necessitated oxygen therapy in 3 patients with severe underlying obstructive airway disease (2 with a pre-existing tracheostomy). The most severe episode occurred in a patient with a febrile respiratory illness and was associated with hypoxia during the infusion, resulting in a short seizure. In the fourth patient, who had less severe underlying disease, spontaneous resolution occurred shortly after the infusion was interrupted. These events did not recur with subsequent infusions using a slower infusion rate and administration of pre-infusion medicinal products, usually low-dose steroids, antihistamine, and beta-agonist nebulisation. The fifth patient, who had preexisting cardiopathy, was diagnosed with ventricular premature complexes and pulmonary embolism during the study.</p><p>There have been post-marketing reports of anaphylactoid/anaphylactic reactions (see section 4.4).<br />Patients with complete deletion/large rearrangement genotype have a higher probability of developing infusion related adverse events (see section 4.4).<br /><u>Immunogenicity</u><br />Across 4 clinical studies (TKT008, TKT018, TKT024 and TKT024EXT), 53/107 patients (50%) developed anti-idursulfase IgG antibodies at some point. The overall neutralizing antibody rate was 26/107 patients (24%).</p><p>In the post-hoc immunogenicity analysis of data from TKT024/024EXT studies, 51% (32/63) patients treated with 0.5mg/kg weekly idursulfase had at least 1 blood sample that tested positive for antiidursulfase antibodies, and 37 % (23/63) tested positive for antibodies on at least 3 consecutive study visits. Twenty-one percent (13/63) tested positive for neutralizing antibodies at least once and 13 % (8/63) tested positive for neutralizing antibodies on at least 3 consecutive study visits.</p><p>Clinical study HGT-ELA-038 evaluated immunogenicity in children 16 months to 7.5 years of age. During the 53-week study, 67.9% (19 of 28) of patients had at least one blood sample that tested positive for anti-idursulfase antibodies, and 57.1% (16 of 28) tested positive for antibodies on at least three consecutive study visits. Fifty-four percent of patients tested positive for neutralizing antibodies at least once and half of the patients tested positive for neutralizing antibodies on at least three consecutive study visits.</p><p>All patients with the complete deletion/large rearrangement genotype developed antibodies, and the majority of them (7/8) also tested positive for neutralizing antibodies on at least 3 consecutive occasions. All patients with the frameshift/splice site mutation genotype developed antibodies and 4/6 also tested positive for neutralizing antibodies on at least 3 consecutive study visits. Antibodynegative patients were found exclusively in the issense mutation genotype group (see sections 4.4 and 5.1).</p><p><u>Paediatric population</u><br />Adverse reactions reported in the paediatric population were, in general, similar to those reported in adults.<br />&nbsp;</p><p><u>Reporting of suspected adverse reactions</u><br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no experience with overdoses of Elaprase.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Other alimentary tract and metabolism products &ndash; enzymes, ATC code: A16AB09.<br /><u>Mechanism of action</u><br />Hunter syndrome is an X-linked disease caused by insufficient levels of the lysosomal enzyme iduronate-2-sulfatase. Iduronate-2-sulfatase functions to catabolize the glycosaminoglycans (GAG) dermatan sulfate and heparan sulfate by cleavage of oligosaccharide-linked sulfate moieties. Due to the missing or defective iduronate-2-sulfatase enzyme in patients with Hunter syndrome,</p><p>glycosaminoglycans progressively accumulate in the cells, leading to cellular engorgement,<br />organomegaly, tissue destruction, and organ system dysfunction.</p><p>Idursulfase is a purified form of the lysosomal enzyme iduronate-2-sulfatase, produced in a human cell line providing a human glycosylation profile, which is analogous to the naturally occurring enzyme. Idursulfase is secreted as a 525 amino acid glycoprotein and contains 8 N-linked glycosylation sites that are occupied by complex, hybrid, and high-mannose type oligosaccharide chains. Idursulfase has a molecular weight of approximately 76 kD.</p><p>Treatment of Hunter syndrome patients with intravenous idursulfase provides exogenous enzyme for uptake into cellular lysosomes. Mannose-6-phosphate (M6P) residues on the oligosaccharide chains allow specific binding of the enzyme to the M6P receptors on the cell surface, leading to cellular internalization of the enzyme, targeting to intracellular lysosomes and subsequent catabolism of accumulated GAG.</p><p><u>Clinical efficacy and safety</u><br />The safety and efficacy of Elaprase has been shown in three clinical studies: two randomised, placebo-controlled clinical studies (TKT008 and TKT024) in adults and children above the age of 5 years and one open-label, safety study (HGT-ELA-038) in children between the age of 16 months and 7.5 years.<br />A total of 108 male Hunter syndrome patients with a broad spectrum of symptoms were enrolled in the two randomized, placebo-controlled clinical studies, 106 continued treatment in two open-label, extension studies.</p><p>Study TKT024<br />In a 52-week, randomized, double-blind, placebo-controlled clinical study, 96 patients between the ages of 5 and 31 years received Elaprase 0.5 mg/kg every week (n=32) or 0.5 mg/kg every other week (n=32), or placebo (n=32). The study included patients with a documented deficiency in iduronate-2- sulfatase enzyme activity, a percent predicted FVC &lt;80%, and a broad spectrum of disease severity.</p><p>The primary efficacy endpoint was a two component composite score based on the sum of the rank of the change from baseline to the end of the study in the distance walked during six minutes (6- minute walk test or 6MWT) as a measure of endurance, and % predicted forced vital capacity (FVC) as a measure of pulmonary function. This endpoint differed significantly from placebo for patients<br />treated weekly (p=0.0049).<br />Additional clinical benefit analyses were performed on individual components of the primary endpoint composite score, absolute changes in FVC, changes in urine GAG levels, liver and spleen volumes, measurement of forced expiratory volume in 1 second (FEV1), and changes in left ventricular mass (LVM). The results are presented in Table 2.</p><p><strong>Table 2. Results from pivotal clinical study at 0.5 mg/kg per week (Study TKT024).</strong></p><p><img alt="" width="700" height="252" src="data:image/png;base64,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" /></p><p><img alt="" width="700" height="177" src="data:image/png;base64,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" /></p><p>A total of 11 of 31 (36%) patients in the weekly treatment group versus 5 of 31 (16%) patients in the placebo group had an increase in FEV1 of at least 0.02 l at or before the end of the study, indicating a dose-related improvement in airway obstruction. The patients in the weekly treatment group experienced a clinically significant 15% mean improvement in FEV1 at the end of the study.</p><p>Urine GAG levels were normalized below the upper limit of normal (defined as 126.6 &mu;g GAG/mg creatinine) in 50% of the patients receiving weekly treatment.</p><p>Of the 25 patients with abnormally large livers at baseline in the weekly treatment group, 80% (20 patients) had reductions in liver volume to within the normal range by the end of the study.</p><p>Of the 9 patients in the weekly treatment group with abnormally large spleens at baseline, 3 had spleen volumes that normalized by the end of the study.</p><p>Approximately half of the patients in the weekly treatment group (15 of 32; 47%) had left ventricular hypertrophy at baseline, defined as LVM index 103 g/m2. Of these 6 (40%) had normalised LVM by the end of the study.</p><p>All patients received weekly idursulfase up to 3.2 years in an extension to this study (TKT024EXT).</p><p>Among patients who were originally randomised to weekly idursulfase in TKT024, mean maximum improvement in distance walked during six minutes occurred at Month 20 and mean percent predicted FVC peaked at Month 16.</p><p>Among all patients, statistically significant mean increases from treatment baseline (TKT024 baseline for TKT024 idursulfase patients and Week 53 baseline for TKT024 placebo patients) were seen in the distance walked 6MWT at the majority of time points tested, with significant mean and percent increases ranging from 13.7m to 41.5m (maximum at Month 20) and from 6.4% to 13.3% (maximum at Month 24) respectively. At most time points tested, patients who were from the original TKT024 weekly treatment group improved their walking distance to a greater extent that patients in the other 2 treatment groups.<br />Among all patients, mean % predicted FVC was significantly increased at Month 16, although by Month 36, it was similar to the baseline. Patients with the most severe pulmonary impairment at baseline (as measured by % predicted FVC) tended to show the least improvement.</p><p>Statistically significant increases from treatment baseline in absolute FVC volume were seen at most visits for all treatment groups combined and for each of the prior TKT024 treatment groups. Mean changes from 0.07 l to 0.31 l and percent ranged from 6.3% to 25.5% (maximum at Month 30). The mean and percent changes from treatment baseline were greatest in the group of patients from the TKT024 study who had received the weekly dosing, across all time points.</p><p>At their final visit 21/31 patients in the TKT024 Weekly group, 24/32 in the TKT024 EOW group and 18/31 patients in the TKT024 placebo group had final normalised urine GAG levels that were below the upper limit of normal. Changes in urinary GAG levels were the earliest signs of clinical improvement with idursulfase treatment and the greatest decreases in urinary GAG were seen within the first 4 months of treatment in all treatment groups; changes from Month 4 to 36 were small. The&nbsp;higher the urinary GAG levels at baseline, the greater the magnitude of decreases in urinary GAG with idursulfase treatment.</p><p>The decreases in liver and spleen volumes observed at the end of study TKT024 (week 53) were maintained during the extension study (TKT024EXT) in all patients regardless of the prior treatmen they had been assigned. Liver volume normalised by Month 24 for 73% (52 out of 71) of patients with hepatomegaly at baseline. In addition, mean liver volume decreased to a near maximum extent by Month 8 in all patients previously treated, with a slight increase observed at Month 36. The decreases in mean liver volume were seen regardless of age, disease severity, IgG antibody status or neutralising antibody status. Spleen volume normalised by Months 12 and 24 for 9.7% of patients in the TKT024 Weekly group with splenomegaly.</p><p>Mean cardiac LVMI remained stable over 36 months of idursulfase treatment within each TKT024 treatment group.<br />In a post-hoc analysis of immunogenicity in studies TKT024 and TKT024EXT (see section 4.8), patients were shown to have either the mis-sense mutation or the frameshift / nonsense mutation. After 105 weeks of exposure to idursulfase, neither antibody status nor genotype affected reductions in liver and spleen size or distance walked in the 6-minute walk test or forced vital capacity measurements. Patients who tested antibody-positive displayed less reduction in urinary output of glycosaminoglycans than antibody-negative patients. The longer-term effects of antibody development on clinical outcomes have not been established.</p><p><u>Study HGT-ELA-038</u><br />This was an open-label, multicenter, single-arm study of idursulfase infusions in male Hunter syndrome patients between the age of 16 months and 7.5 years.<br />Idursulfase treatment resulted in up to 60% reduction in urine output of glycosaminoglycans and in reductions of liver and spleen size: results were comparable to those found in study TKT024. Reductions were evident by week 18 and were maintained to week 53. Patients who developed a high titre of antibodies displayed less response to idursulfase as assessed by urine output of glycosaminoglycans and by liver and spleen size.<br />&nbsp;</p><p><u><em>Analyses of genotypes of patients in study HGT-ELA-038</em></u><br />Patients were classified into the following groups: missense (13), complete deletion/large rearrangement (8), and frameshift/ splice site mutations (5). One patient was unclassified / unclassifiable.</p><p>The complete deletion/ large rearrangement genotype was most commonly associated with development of high titre of antibodies and neutralising antibodies to idursulfase and was most likely to display a muted response to the medicinal product. It was not possible, however, to accurately predict individual clinical outcome based on antibody response or genotype.</p><p>No clinical data exist demonstrating a benefit on the neurological manifestations of the disorder.</p><p>This medicinal product has been authorised under &ldquo;exceptional circumstances&rdquo;.<br />This means that due to the rarity of the disease it has not been possible to obtain complete information&nbsp;this medicinal product.<br />The European Medicines Agency will review any new information which may become available every year and this SmPC will be updated as necessary.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Idursulfase is taken up by selective receptor-mediated mechanisms involving binding to mannose 6-phosphate receptors. Upon internalization by cells, it is localized within cellular lysosomes, thereby limiting&nbsp;distribution of the protein. Degradation of idursulfase is achieved by generally well understood protein hydrolysis mechanisms to produce small peptides and amino acids, consequently renal and liver function impairment is not expected to affect the pharmacokinetics of idursulfase.</p><p>Pharmacokinetic parameters measured during the first infusion at week 1 of studies TKT024 (0.5 mg/kg weekly arm) and HGT-ELA-038 are displayed in table 3 and table 4 below as a function of age and body weight, respectively.</p><p><strong>Table 3. Pharmacokinetic parameters at week 1 as a function of age in Studies TKT024 and<br />HGT-ELA-038</strong></p><p><img alt="" width="650" height="263" src="data:image/png;base64,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" /></p><p>Patients in the TKT024 and HGT-ELA-038 studies were also stratified across five weight categories; as shown in the following table:<br /><strong>Table 4. Pharmacokinetic parameters at week 1 as a function of body weight in studies TKT024 and HGT-ELA-038</strong></p><p><strong><img alt="" width="650" height="207" src="data:image/png;base64,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" /></strong></p><p>A higher volume of distribution at steady state (Vss) was observed in the lowest weight groups.<br />Overall, there was no apparent trend in either systemic exposure or clearance rate of idursulfase with respect to either age or body weight.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nonclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, single dose toxicity, repeated dose toxicity, toxicity to reproduction and development and to male fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Polysorbate 20</li><li>Sodium chloride</li><li>Dibasic sodium phosphate heptahydrate</li><li>Monobasic sodium phosphate monohydrate</li><li>Water for injections</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Store in a refrigerator (2<sup>o</sup>C-8<sup>o</sup>C)</li><li>Do not freeze.</li><li>For storage conditions after dilution of the medicinal product,</li></ul><p>Chemical and physical in-use stability has been demonstrated for 8 hours at 25&deg;C.<br /><strong>After dilution</strong><br />From a microbiological safety point of view, the diluted product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours at 2 to 8&deg;C.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>5 ml vial (type I glass) with a stopper (fluoro-resin coated butyl rubber), one piece seal and blue flip-off cap. Each vial contains 3 ml of concentrate for solution for infusion.</li><li>Pack sizes of 1, 4 and 10 vials.</li><li>Not all pack sizes may be marketed.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Each vial of Elaprase is intended for single use only and contains 6 mg of idursulfase in 3 ml of solution. Elaprase is for intravenous infusion and must be diluted in sodium chloride 9 mg/ml (0.9%) solution for infusion prior to use. It is recommended to deliver the total volume of infusion using a 0.2 &mu;m in line filter. Elaprase should not be infused with other medicinal products in the infusion tubing.</p><ul><li>The number of vials to be diluted should be determined based on the individual patient&rsquo;s weight and the recommended dose of 0.5 mg/kg.</li><li>The solution in the vials should not be used if it is discoloured or if particulate matter is present. The solution should not be shaken.</li><li>The calculated volume of Elaprase should be withdrawn from the appropriate number of vials.</li><li>The total volume required of Elaprase should be diluted in 100 ml of 9 mg/ml (0.9%) sodium chloride solution for infusion. Care must be taken to ensure the sterility of the prepared solutions since Elaprase does not contain any preservative or bacteriostatic agent; aseptic technique must be observed. Once diluted, the solution should be mixed gently, but not shaken.</li></ul><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Shire Human Genetic Therapies AB, Vasagatan 7, 111 20 Stockholm, Sweden
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09/2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>